ζ‐Chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia
暂无分享,去创建一个
D. Catovsky | R. A’Hern | E. Matutes | J. Swansbury | R. Morilla | A. Morilla | I. Del Giudice | V. Brito‐Babapulle | N. Osuji | A. Burford | K. Owusu‐Ankomah | Sonia Maravelaki
[1] L. Klein-Hitpass,et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[2] L. Rassenti,et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. , 2005, Blood.
[3] G. Guida,et al. CD38 modifications in chronic lymphocytic leukemia: are they relevant? , 2004, Leukemia.
[4] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.
[5] Adrian Wiestner,et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.
[6] D. Catovsky,et al. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. , 2004, The hematology journal : the official journal of the European Haematology Association.
[7] T. Möröy,et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia , 2003, Leukemia.
[8] Adrian Wiestner,et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.
[9] Emili Montserrat,et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.
[10] Arthur Weiss,et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.
[11] Axel Benner,et al. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.
[12] D. Oscier,et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.
[13] D. Oscier,et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.
[14] R. Bataille,et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia , 2002, British journal of haematology.
[15] L. Bullinger,et al. VH mutation status , CD 38 expression level , genomic aberrations , and survival in chronic lymphocytic leukemia , 2002 .
[16] David Botstein,et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.
[17] G. Capelli,et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. , 2001, Blood.
[18] K. Do,et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. , 2001, Blood.
[19] A Benner,et al. Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.
[20] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[21] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[22] Terry J. Hamblin,et al. Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia , 1999 .
[23] D. Catovsky,et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12 , 1997, British journal of haematology.
[24] Robert Vlietinck,et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases , 1997, British journal of haematology.
[25] D. Catovsky,et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients , 1996, British journal of haematology.
[26] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[27] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .